STUDY OF QUALITY OF LIFE WITH THE HELP OF IT-TECHNOLOGIES IN PATIENTS WITH HEMOPHILIA

OBJECTIVES: Since 2007, patients with hemophilia enable treatment of blood coagulation factors in the amount of 5IU per capita, in Europe the figure is about 4, (2 to 11IU in different countries). In 2008-2011, we have examined the patients QoL with hemophilia in Russia, Ukraine and Kazakhstan. Avai...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Value in health 2017-05, Vol.20 (5), p.A228
Hauptverfasser: Vorobiev, P, Vorobiev, A, Dugin, D, Krasnova, L, Zhulev, Y, Zykova, A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 5
container_start_page A228
container_title Value in health
container_volume 20
creator Vorobiev, P
Vorobiev, A
Dugin, D
Krasnova, L
Zhulev, Y
Zykova, A
description OBJECTIVES: Since 2007, patients with hemophilia enable treatment of blood coagulation factors in the amount of 5IU per capita, in Europe the figure is about 4, (2 to 11IU in different countries). In 2008-2011, we have examined the patients QoL with hemophilia in Russia, Ukraine and Kazakhstan. Availability of Internet allows you to implement this task with the help of software. In 2015, it was developed a program MeDiCase to assess the QoL of remote villages residents with a smart-phone. METHODS: The questionnaire, including an assessment of the quality of life for the EQ-5D with a VAS was posted on the web-site of the Russian Society of hemophiliacs (http://hemophilia2016.tilda.ws.) RESULTS: The web-survey completed by 79 people - about 1.2% of patients receiving therapy with clotting factors on a government program(N=6793): 88%with "A"hemophilia and 12%"B". The average age - 30 years. In large cities live 67%, in small cities 17%, 16%in villages. QoL assessment on the EQ-5D questionnaire revealed that there are no problems with movement in space in 50% of people, small problems -49% extreme problems at 1%. Self-service: no problems -79% of patients with minor problems -17% extreme problems at 4%. Daily Activity: there are no problems in 51% of patients with minor problems -45% extreme problems at 4%. Pain and discomfort there are no problems in 25%, small problems -63% extreme problems 12%. Anxiety and depression: there are no problems in 46%, small problems -43% extreme problems -11%. Respondents rated their quality of life (VAS) as a 63(19tol00). In 2008, the quality of life (VAS) was exactly 60, patients with the presence of antibodies to coagulation factors - 52. CONCLUSIONS: The use of IT-technologies allows patients studies via the Internet, including - with hemophilia, to assess the QoL with the EQ-5D questionnaire.
doi_str_mv 10.1016/j.jval.2017.05.005
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2097660952</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2097660952</sourcerecordid><originalsourceid>FETCH-proquest_journals_20976609523</originalsourceid><addsrcrecordid>eNqNirFuwjAURS0EElD6A0yWOsd9tnFCxog69ZNMEpQXVUxRhjBEUWlJ6fcDhQ_odI_uOYwtJQgJMnztRPfb9EKBjAQYAWBGbCaNWgWrSOvxlSFeBxqkmbL5MHQAEGplZqwqqXrb8zzluyrxSH_oMbX8A8lxcpY764vbixSQ3bgs9_k72pJjxouE0GZU3mNnt3nh0GOyYJND0w_t82Of2EtqaeOCr9Px-9wOP3V3PJ8-r6pWEEdhCLFR-n_VBcaLP5E</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2097660952</pqid></control><display><type>article</type><title>STUDY OF QUALITY OF LIFE WITH THE HELP OF IT-TECHNOLOGIES IN PATIENTS WITH HEMOPHILIA</title><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Vorobiev, P ; Vorobiev, A ; Dugin, D ; Krasnova, L ; Zhulev, Y ; Zykova, A</creator><creatorcontrib>Vorobiev, P ; Vorobiev, A ; Dugin, D ; Krasnova, L ; Zhulev, Y ; Zykova, A</creatorcontrib><description>OBJECTIVES: Since 2007, patients with hemophilia enable treatment of blood coagulation factors in the amount of 5IU per capita, in Europe the figure is about 4, (2 to 11IU in different countries). In 2008-2011, we have examined the patients QoL with hemophilia in Russia, Ukraine and Kazakhstan. Availability of Internet allows you to implement this task with the help of software. In 2015, it was developed a program MeDiCase to assess the QoL of remote villages residents with a smart-phone. METHODS: The questionnaire, including an assessment of the quality of life for the EQ-5D with a VAS was posted on the web-site of the Russian Society of hemophiliacs (http://hemophilia2016.tilda.ws.) RESULTS: The web-survey completed by 79 people - about 1.2% of patients receiving therapy with clotting factors on a government program(N=6793): 88%with "A"hemophilia and 12%"B". The average age - 30 years. In large cities live 67%, in small cities 17%, 16%in villages. QoL assessment on the EQ-5D questionnaire revealed that there are no problems with movement in space in 50% of people, small problems -49% extreme problems at 1%. Self-service: no problems -79% of patients with minor problems -17% extreme problems at 4%. Daily Activity: there are no problems in 51% of patients with minor problems -45% extreme problems at 4%. Pain and discomfort there are no problems in 25%, small problems -63% extreme problems 12%. Anxiety and depression: there are no problems in 46%, small problems -43% extreme problems -11%. Respondents rated their quality of life (VAS) as a 63(19tol00). In 2008, the quality of life (VAS) was exactly 60, patients with the presence of antibodies to coagulation factors - 52. CONCLUSIONS: The use of IT-technologies allows patients studies via the Internet, including - with hemophilia, to assess the QoL with the EQ-5D questionnaire.</description><identifier>ISSN: 1098-3015</identifier><identifier>EISSN: 1524-4733</identifier><identifier>DOI: 10.1016/j.jval.2017.05.005</identifier><language>eng</language><publisher>Lawrenceville: Elsevier Science Ltd</publisher><subject>Antibodies ; Anxiety ; Blood ; Blood coagulation ; Clotting ; Coagulation factors ; Discomfort ; Hemophilia ; Internet ; Mental depression ; Pain ; Patients ; Polls &amp; surveys ; Quality of life ; Questionnaires ; Small cities ; Software ; Telemedicine ; Villages</subject><ispartof>Value in health, 2017-05, Vol.20 (5), p.A228</ispartof><rights>Copyright Elsevier Science Ltd. May 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902,30976</link.rule.ids></links><search><creatorcontrib>Vorobiev, P</creatorcontrib><creatorcontrib>Vorobiev, A</creatorcontrib><creatorcontrib>Dugin, D</creatorcontrib><creatorcontrib>Krasnova, L</creatorcontrib><creatorcontrib>Zhulev, Y</creatorcontrib><creatorcontrib>Zykova, A</creatorcontrib><title>STUDY OF QUALITY OF LIFE WITH THE HELP OF IT-TECHNOLOGIES IN PATIENTS WITH HEMOPHILIA</title><title>Value in health</title><description>OBJECTIVES: Since 2007, patients with hemophilia enable treatment of blood coagulation factors in the amount of 5IU per capita, in Europe the figure is about 4, (2 to 11IU in different countries). In 2008-2011, we have examined the patients QoL with hemophilia in Russia, Ukraine and Kazakhstan. Availability of Internet allows you to implement this task with the help of software. In 2015, it was developed a program MeDiCase to assess the QoL of remote villages residents with a smart-phone. METHODS: The questionnaire, including an assessment of the quality of life for the EQ-5D with a VAS was posted on the web-site of the Russian Society of hemophiliacs (http://hemophilia2016.tilda.ws.) RESULTS: The web-survey completed by 79 people - about 1.2% of patients receiving therapy with clotting factors on a government program(N=6793): 88%with "A"hemophilia and 12%"B". The average age - 30 years. In large cities live 67%, in small cities 17%, 16%in villages. QoL assessment on the EQ-5D questionnaire revealed that there are no problems with movement in space in 50% of people, small problems -49% extreme problems at 1%. Self-service: no problems -79% of patients with minor problems -17% extreme problems at 4%. Daily Activity: there are no problems in 51% of patients with minor problems -45% extreme problems at 4%. Pain and discomfort there are no problems in 25%, small problems -63% extreme problems 12%. Anxiety and depression: there are no problems in 46%, small problems -43% extreme problems -11%. Respondents rated their quality of life (VAS) as a 63(19tol00). In 2008, the quality of life (VAS) was exactly 60, patients with the presence of antibodies to coagulation factors - 52. CONCLUSIONS: The use of IT-technologies allows patients studies via the Internet, including - with hemophilia, to assess the QoL with the EQ-5D questionnaire.</description><subject>Antibodies</subject><subject>Anxiety</subject><subject>Blood</subject><subject>Blood coagulation</subject><subject>Clotting</subject><subject>Coagulation factors</subject><subject>Discomfort</subject><subject>Hemophilia</subject><subject>Internet</subject><subject>Mental depression</subject><subject>Pain</subject><subject>Patients</subject><subject>Polls &amp; surveys</subject><subject>Quality of life</subject><subject>Questionnaires</subject><subject>Small cities</subject><subject>Software</subject><subject>Telemedicine</subject><subject>Villages</subject><issn>1098-3015</issn><issn>1524-4733</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>7QJ</sourceid><recordid>eNqNirFuwjAURS0EElD6A0yWOsd9tnFCxog69ZNMEpQXVUxRhjBEUWlJ6fcDhQ_odI_uOYwtJQgJMnztRPfb9EKBjAQYAWBGbCaNWgWrSOvxlSFeBxqkmbL5MHQAEGplZqwqqXrb8zzluyrxSH_oMbX8A8lxcpY764vbixSQ3bgs9_k72pJjxouE0GZU3mNnt3nh0GOyYJND0w_t82Of2EtqaeOCr9Px-9wOP3V3PJ8-r6pWEEdhCLFR-n_VBcaLP5E</recordid><startdate>20170501</startdate><enddate>20170501</enddate><creator>Vorobiev, P</creator><creator>Vorobiev, A</creator><creator>Dugin, D</creator><creator>Krasnova, L</creator><creator>Zhulev, Y</creator><creator>Zykova, A</creator><general>Elsevier Science Ltd</general><scope>7QJ</scope></search><sort><creationdate>20170501</creationdate><title>STUDY OF QUALITY OF LIFE WITH THE HELP OF IT-TECHNOLOGIES IN PATIENTS WITH HEMOPHILIA</title><author>Vorobiev, P ; Vorobiev, A ; Dugin, D ; Krasnova, L ; Zhulev, Y ; Zykova, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_20976609523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Antibodies</topic><topic>Anxiety</topic><topic>Blood</topic><topic>Blood coagulation</topic><topic>Clotting</topic><topic>Coagulation factors</topic><topic>Discomfort</topic><topic>Hemophilia</topic><topic>Internet</topic><topic>Mental depression</topic><topic>Pain</topic><topic>Patients</topic><topic>Polls &amp; surveys</topic><topic>Quality of life</topic><topic>Questionnaires</topic><topic>Small cities</topic><topic>Software</topic><topic>Telemedicine</topic><topic>Villages</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vorobiev, P</creatorcontrib><creatorcontrib>Vorobiev, A</creatorcontrib><creatorcontrib>Dugin, D</creatorcontrib><creatorcontrib>Krasnova, L</creatorcontrib><creatorcontrib>Zhulev, Y</creatorcontrib><creatorcontrib>Zykova, A</creatorcontrib><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><jtitle>Value in health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vorobiev, P</au><au>Vorobiev, A</au><au>Dugin, D</au><au>Krasnova, L</au><au>Zhulev, Y</au><au>Zykova, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>STUDY OF QUALITY OF LIFE WITH THE HELP OF IT-TECHNOLOGIES IN PATIENTS WITH HEMOPHILIA</atitle><jtitle>Value in health</jtitle><date>2017-05-01</date><risdate>2017</risdate><volume>20</volume><issue>5</issue><spage>A228</spage><pages>A228-</pages><issn>1098-3015</issn><eissn>1524-4733</eissn><abstract>OBJECTIVES: Since 2007, patients with hemophilia enable treatment of blood coagulation factors in the amount of 5IU per capita, in Europe the figure is about 4, (2 to 11IU in different countries). In 2008-2011, we have examined the patients QoL with hemophilia in Russia, Ukraine and Kazakhstan. Availability of Internet allows you to implement this task with the help of software. In 2015, it was developed a program MeDiCase to assess the QoL of remote villages residents with a smart-phone. METHODS: The questionnaire, including an assessment of the quality of life for the EQ-5D with a VAS was posted on the web-site of the Russian Society of hemophiliacs (http://hemophilia2016.tilda.ws.) RESULTS: The web-survey completed by 79 people - about 1.2% of patients receiving therapy with clotting factors on a government program(N=6793): 88%with "A"hemophilia and 12%"B". The average age - 30 years. In large cities live 67%, in small cities 17%, 16%in villages. QoL assessment on the EQ-5D questionnaire revealed that there are no problems with movement in space in 50% of people, small problems -49% extreme problems at 1%. Self-service: no problems -79% of patients with minor problems -17% extreme problems at 4%. Daily Activity: there are no problems in 51% of patients with minor problems -45% extreme problems at 4%. Pain and discomfort there are no problems in 25%, small problems -63% extreme problems 12%. Anxiety and depression: there are no problems in 46%, small problems -43% extreme problems -11%. Respondents rated their quality of life (VAS) as a 63(19tol00). In 2008, the quality of life (VAS) was exactly 60, patients with the presence of antibodies to coagulation factors - 52. CONCLUSIONS: The use of IT-technologies allows patients studies via the Internet, including - with hemophilia, to assess the QoL with the EQ-5D questionnaire.</abstract><cop>Lawrenceville</cop><pub>Elsevier Science Ltd</pub><doi>10.1016/j.jval.2017.05.005</doi></addata></record>
fulltext fulltext
identifier ISSN: 1098-3015
ispartof Value in health, 2017-05, Vol.20 (5), p.A228
issn 1098-3015
1524-4733
language eng
recordid cdi_proquest_journals_2097660952
source Applied Social Sciences Index & Abstracts (ASSIA); Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Antibodies
Anxiety
Blood
Blood coagulation
Clotting
Coagulation factors
Discomfort
Hemophilia
Internet
Mental depression
Pain
Patients
Polls & surveys
Quality of life
Questionnaires
Small cities
Software
Telemedicine
Villages
title STUDY OF QUALITY OF LIFE WITH THE HELP OF IT-TECHNOLOGIES IN PATIENTS WITH HEMOPHILIA
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T03%3A17%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=STUDY%20OF%20QUALITY%20OF%20LIFE%20WITH%20THE%20HELP%20OF%20IT-TECHNOLOGIES%20IN%20PATIENTS%20WITH%20HEMOPHILIA&rft.jtitle=Value%20in%20health&rft.au=Vorobiev,%20P&rft.date=2017-05-01&rft.volume=20&rft.issue=5&rft.spage=A228&rft.pages=A228-&rft.issn=1098-3015&rft.eissn=1524-4733&rft_id=info:doi/10.1016/j.jval.2017.05.005&rft_dat=%3Cproquest%3E2097660952%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2097660952&rft_id=info:pmid/&rfr_iscdi=true